-
Calliditas Therapeutics Presents Additional Data Analyses from the Phase 3 NeflgArd trial of Nefecon in Primary IgA Nephropathy at the ISN World Congress of Nephrology 2024
18 Apr 2024 14:19 GMT
… said Richard Philipson, Chief Medical Officer of Calliditas. … Phase 3 trial"
During the 9-month treatment period, … 15 months of off-drug observational follow-up … such as ketoconazole, itraconazole, ritonavir, indinavir, saquinavir, erythromycin, and …
-
Petros Pharmaceuticals Receives Positive Response from FDA Following Recent Demonstration of Technology Component in Pursuit of OTC Status for STENDRA(R) (avanafil)
16 Apr 2024 17:13 GMT
… to medication through over-the- counter (OTC) drug … key prescription pharmaceuticals as Over-the-Counter treatment options. … STENDRA tell your doctor if you have … CYP3A4 inhibitors (including ketoconazole, ritonavir, atazanavir, clarithromycin, indinavir, …
-
Paxlovid COVID Treatment Is Most Beneficial for Unvaccinated People with Risk Factors. Others May Not Need It
12 Apr 2024 21:21 GMT
… drug Paxlovid swiftly entered the U.S. pharmaceutical market … Drug Administration fully approved the oral medication, more than 11.6 million treatment … combination of the drugs nirmatrelvir and ritonavir) may not … the hospital or a doctor. This is what …
-
Drug Trials Snapshots: PAXLOVID
11 Apr 2024 15:08 GMT
… trials that supported the original FDA approval of this drug, … drug used?
PAXLOVID consists of two medicines: nirmatrelvir tablets and ritonavir … ;3 global trial for the treatment of adult outpatients … trial.
PLACEBO: An inactive substance or “sugar pill” …
-
What’s next for COVID-19 drugs?
10 Apr 2024 19:21 GMT
… don’t have many treatment options. The FDA has authorized just … a combination of two drugs — nirmatrelvir and ritonavir — that work together … had at least one medical condition that put them … of a new randomized controlled trial of Paxlovid, involving about …
-
The Potential and Limitations of Antiviral Treatment for COVID-19
09 Apr 2024 21:37 GMT
… symptoms between the treatment group (nirmatrelvir–ritonavir) and the placebo … the treatment group.
In this phase 2–3 trial, adults … from any cause in this trial, although not significant, … distinct taste of nirmatrelvir–ritonavir. The trial's initiation …
-
Nirmatrelvir fails to shorten COVID-19 symptoms in latest trial
09 Apr 2024 02:18 GMT
… in the clinical trials phase.
Nirmatrelvir is … and placebo-controlled trial involving adult participants 18 … sociodemographic, anthropometric, and medical records.
Digital diaries were … between nirmatrelvir-ritonavir and placebo treatment cohorts. While …
-
The Truth Behind Pfizer’s Paxlovid™ Medication
08 Apr 2024 20:34 GMT
… to make big treatment decisions, doctors are usually hesitant … patients who started nirmatrelvir-ritonavir or placebo within … in files at the pharmaceutical company Roche, never … dysfunctional system of conducting medical randomized trials.
Matt Bivens, MD, …
-
Nirmatrelvir–Ritonavir Reduced Mortality in Hospitalized Patients with COVID-19 During the Omicron Outbreak: Real-World Evidence from Beijing
08 Apr 2024 06:45 GMT
… the treatment group. Concomitant treatments … drug interactions of nirmatrelvir–ritonavir, which might necessitate the continuation of contraindicated medications … randomized controlled trials.
Conclusion
In … Controlled Clinical Trial. Pharmaceutics. 2022;14 …
-
U.S. taxpayers on the hook for $13 billion for Pfizer’s Covid drug which ‘doesn’t work’
07 Apr 2024 23:20 GMT
… between participants who received nirmatrelvir–ritonavir (Paxlovid) and those … The Journal of the American Medical Association (JAMA) found … accountable for the greatest pharmaceutical fraud and swindle operation … for Pfizer’s Covid drug which ‘doesn’t work …